Two lots of cystic fibrosis drug Cayston recalled due to the potential of cracked glass vials
Is your product affected? Check the DIN and lot number on your package against the list in Health Canada's official notice.
See affected DINs and lot numbers on Health Canada ↗Why it was recalled
Product quality
What you should do
- Check the lot number on your product or contact your pharmacist to determine whether your product is subject to this recall if you have any doubt. If you have a recalled product, stop taking the medication and contact your pharmacy immediately for a replacement product. Return the affected product to your pharmacy for proper disposal. If you become aware of any unusual symptoms or side effects that may be associated with this product, immediately contact your healthcare provider. Contact Gilead Sciences, Inc., toll-free at 1-800-445-3235, or by e-mail at Safety_fc@gilead.com, if you have questions about this recall. Report any health product adverse events or complaints to Health Canada.
Other Recent Recalls
PDP-DIPHENHYDRAMINE
PDP-DIPHENHYDRAMINE 25 MG and 50 MG CAPSULES: Out-of-specification (Impurity)
Type II2026-11-09
Moderate health risk
Unauthorized injectable peptide and non-peptide drugs
Health Canada warns about contaminated unauthorized injectable peptides and non-peptide drugs
2026-11-06
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP
ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 4g/100mL and Potential Bag Leaks
2026-11-03
Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice — for questions about this recall, contact the manufacturer or your pharmacist, or read the full notice linked above.